Skip to main content
OpenTrials
Completed

NCT Number: NCT02061618

Culturally Relevant Exercise for Diabetes (CURE-D)

The Culturally Relevant Exercise for Diabetes (CURE-D) study will determine whether a culturally-sensitive dance intervention is an accepted and effective physical intervention for South Asian women with type 2 diabetes mellitus. The CURE-D study will determine if Bollywood dance exercise improves diabetes outcomes in South Asian women.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases

Age range

18 year–85 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Palo Alto Medical Foundation Research Institute

Palo Alto, California, 94301, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Sex: Females
  • Ethnicity: South Asian
  • Hemoglobin A1c ≥ 6.0 mg/dL
  • A PAMF patient for ≥ 24 months
  • Able and willing to enroll and meet the requirements of the study.

Exclusion criteria

  • BMI > 35
  • Insulin dependent
  • Current atrial fibrillation
  • Active treatment for cancer
  • Diagnosis of a terminal illness and/or in hospice care
  • Any serious medical condition which would prevent long-term participation or which would contraindicate physical activity
  • Pregnant, lactating, or planning to become pregnant during the study period
  • Inability to speak, read, or understand English
  • No longer a PAMF patient or planning to transfer care outside of PAMF during the study period
  • Investigator discretion for clinical safety or protocol adherence reasons.

Treatment and study plan

Bollywood Dance Exercise

Behavioral

Primary outcomes

  1. Hemoglobin A1c

    Time frame: Baseline

  2. Hemoglobin A1c

    Time frame: 8-week follow-up

    Change from Baseline in Hemoglobin A1c level at 8 weeks

Secondary outcomes

  1. Body Mass Index

    Time frame: Baseline, 8-week follow-up

  2. Blood Pressure

    Time frame: Baseline, 8-week follow-up

  3. Physical Activity

    Time frame: Baseline, 8-week follow-up

    Assessed by accelerometers

Sponsors and collaborators

Lead sponsor

Palo Alto Medical Foundation

Other

Registry information

Acronym: CURE-D

Important dates

Study start
2014
Primary completion
2014
Study completion
2014
First posted
Feb 13, 2014
Registry last updated
Apr 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.